The influence of early transplantation, age, GVHD prevention regimen, and other factors on outcome of allogeneic transplantation for CML following BuCy. Long-term molecular remission induced by donor lymphocyte infusions for recurrent acute myeloblastic leukemia after allogeneic bone marrow transplantation. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia. Verfaillie CM et al. Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation.
Donor leukocyte infusions in acute lymphocytic leukemia.
Abstract Related articles OHTA H, Kawai M, Sawada A, et al. Juvenile myelomonocytic leukemia relapsing after allogeneic bone marrow transplantation successfully treated with interferon-alpha. Busulfan pharmacokinetics do not predict relapse in acute myeloid leukemia. Fatal invasive cerebral Absidia corymbifera infection following bone marrow transplantation. Searching for a cord blood unit for transplantation based on the unit's cell count.